Lipids

"Lipids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)

Descriptor ID	D008055
MeSH Number(s)	D10
Concept/Terms	Lipids Lipids

Below are MeSH descriptors whose meaning is more general than "Lipids".

Chemicals and Drugs [D]
Lipids [D10]

Below are MeSH descriptors whose meaning is related to "Lipids".

Below are MeSH descriptors whose meaning is more specific than "Lipids".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lipids" by people in this website by year, and whether "Lipids" was a major or minor topic of these publications.

Bar chart showing 261 publications over 31 distinct years, with a maximum of 19 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	2	0	2
1996	1	3	4
1997	1	0	1
1998	0	1	1
1999	2	0	2
2000	1	0	1
2001	1	0	1
2002	1	6	7
2003	3	2	5
2004	1	5	6
2005	5	7	12
2006	7	6	13
2007	2	4	6
2008	5	9	14
2009	8	6	14
2010	9	10	19
2011	4	8	12
2012	4	4	8
2013	2	5	7
2014	1	13	14
2015	12	4	16
2016	5	8	13
2017	3	5	8
2018	9	4	13
2019	11	6	17
2020	9	7	16
2021	2	6	8
2022	1	5	6
2023	0	5	5
2024	4	3	7
2025	3	0	3

Below are the most recent publications written about "Lipids" by people in Profiles.

Fernandes RS, de Assis Burle-Caldas G, Sergio SAR, Br?z AF, da Silva Leite NP, Pereira M, de Oliveira Silva J, Hojo-Souza NS, de Oliveira B, Fernandes APSM, da Fonseca FG, Gazzinelli RT, Dos Santos Ferreira D, Teixeira SMR. The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens. J Nanobiotechnology. 2025 Mar 18; 23(1):221.

View in: PubMed
Jaecklein E, Papavinasasundaram K, Ostroff GR, Sassetti C, Soto ER. Targeted delivery of antitubercular drugs using glucan lipid particles. Microbiol Spectr. 2025 Mar 04; 13(3):e0274424.

View in: PubMed
Liu K, He H, Liu M, Hu YQ, Lu LW, Liu B, Chen JH. Evaluating the differential benefits of varying carbohydrate-restricted diets on lipid profiles and cardiovascular risks in dyslipidemia: a meta-analysis and systematic review. Food Funct. 2025 Feb 03; 16(3):831-852.

View in: PubMed
Guo X, Liu H, Hou R, Chen G, Xiao H, Liu L, Ciftci ON, Liu L. Design strategies of polysaccharide, protein and lipid-based nano-delivery systems in improving the bioavailability of polyphenols and regulating gut homeostasis. Int J Biol Macromol. 2024 Dec; 283(Pt 4):137463.

View in: PubMed
Surve D, Fish A, Debnath M, Pinjari A, Lorenzana A, Piya S, Peyton S, Kulkarni A. Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy. Nat Commun. 2024 Oct 19; 15(1):9035.

View in: PubMed
Mittal E, Prasad GVRK, Upadhyay S, Sadadiwala J, Olive AJ, Yang G, Sassetti CM, Philips JA. Mycobacterium tuberculosis virulence lipid PDIM inhibits autophagy in mice. Nat Microbiol. 2024 Nov; 9(11):2970-2984.

View in: PubMed
Pappas DA, Reed G, Kane K, Curtis JR, Charles-Schoeman C, Giles JT, Kremer JM. Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients. Semin Arthritis Rheum. 2024 Oct; 68:152504.

View in: PubMed
Liu X, Song Z, Tian W, Huang Q, Chen M, Huang Y, Xiao H, Xiao J. Advancements in lipid-based delivery systems for functional foods: a comprehensive review of literature and patent trends. Crit Rev Food Sci Nutr. 2025; 65(13):2456-2472.

View in: PubMed
Driscoll DF, Bistrian BR. Pharmaceutical Considerations and Metabolic Fate of Parenteral Lipid Nanoparticle Dosage Forms. J Pharm Sci. 2024 Aug; 113(8):2560-2564.

View in: PubMed
Bardoczi JB, Rossen M, Eugster N, Agoritsas T, Gencer B, Rodondi N. [For which patients do the latest lipid lowering treatments reduce cardiovascular events?] Rev Med Suisse. 2024 Mar 06; 20(864):472-479.

View in: PubMed

People

Explore

Similar Concepts

Top Journals